W. Jahnen-dechent and M. Ketteler, Magnesium basics. Clin. Kidney J, vol.2012, issue.5, pp.3-14

J. R. Weisinger, Magnesium and phosphorus, The Lancet, vol.352, issue.9125, pp.391-396, 1998.
DOI : 10.1016/S0140-6736(97)10535-9

W. J. Fawcett, E. J. Haxby, and D. A. Male, Magnesium, Obstetric Anesthesia Digest, vol.19, issue.3, pp.302-320, 1999.
DOI : 10.1097/00132582-199912000-00006

N. W. Tietz, A. D. Rinker, and S. R. Morrison, When is a serum iron really a serum iron? The status of serum iron measurements, Clin. Chem, vol.40, pp.546-551, 1994.

M. Kanbay, D. Goldsmith, M. E. Uyar, F. Turgut, and A. Covic, Magnesium in Chronic Kidney Disease: Challenges and Opportunities, Blood Purification, vol.29, issue.3, pp.280-292, 2010.
DOI : 10.1159/000276665

W. J. Fawcett, E. J. Haxby, and D. A. Male, CrossRef] [PubMed] 2. Weisinger, pp.3-14, 1998.

N. W. Tietz, A. D. Rinker, and S. R. Morrison, When is a serum iron really a serum iron? The status of serum iron measurements Magnesium in chronic kidney disease: Challenges and opportunities. Blood Purif, Clin. Chem, vol.40, issue.29, pp.546-551, 1994.

J. Cunningham, M. Rodríguez, and P. Messa, Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients, Clinical Kidney Journal, vol.12, issue.4, pp.39-51
DOI : 10.1080/07315724.2009.10719764

R. Whang and K. W. Ryder, Frequency of Hypomagnesemia and Hypermagnesemia, JAMA, vol.263, issue.22, pp.3063-3064, 1990.
DOI : 10.1001/jama.1990.03440220087036

Z. S. Agus, E. Kelepouris, I. Dukes, and M. Morad, Cytosolic magnesium modulates calcium channel activity in mammalian ventricular cells, American Journal of Physiology-Cell Physiology, vol.19, issue.2, pp.452-455, 1989.
DOI : 10.1126/science.2448878

N. Hashizume and M. Mori, An analysis of hypermagnesemia and hypomagnesemia., Japanese Journal of Medicine, vol.29, issue.4, pp.368-372, 1990.
DOI : 10.2169/internalmedicine1962.29.368

H. Kafka, L. Langevin, and P. W. Armstrong, Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias, Archives of Internal Medicine, vol.147, issue.3, pp.465-469, 1987.
DOI : 10.1001/archinte.147.3.465

L. S. Aglio, G. G. Stanford, R. Maddi, J. L. Boyd, S. Nussbaum et al., Hypomagnesemia is common following cardiac surgery, Journal of Cardiothoracic and Vascular Anesthesia, vol.5, issue.3, pp.201-208, 1991.
DOI : 10.1016/1053-0770(91)90274-W

M. R. England, G. Gordon, M. Salem, and B. Chernow, Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial, JAMA: The Journal of the American Medical Association, vol.268, issue.17, pp.2395-2402, 1992.
DOI : 10.1001/jama.268.17.2395

Z. S. Agus and . J. Hypomagnesemia, Am. Soc. Nephrol, vol.10, pp.1616-1622, 1999.

A. C. Truttmann, R. Faraone, R. O. Von-vigier, J. M. Nuoffer, R. Pfister et al., Maintenance Hemodialysis and Circulating Ionized Magnesium, Nephron, vol.92, issue.3, pp.616-621, 2002.
DOI : 10.1159/000064109

M. J. Blumenkrantz, J. D. Kopple, J. K. Moran, and J. W. Coburn, Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis, Kidney International, vol.21, issue.6, pp.849-861, 1982.
DOI : 10.1038/ki.1982.109

E. Ishimura, S. Okuno, T. Yamakawa, M. Inaba, and Y. Nishizawa, Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients, Magnes. Res, vol.20, pp.237-244, 2007.

Y. Sakaguchi, N. Fujii, T. Shoji, T. Hayashi, and H. Rakugi, Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis, Kidney International, vol.85, issue.1, pp.174-181
DOI : 10.1038/ki.2013.327

H. E. Meema, D. G. Oreopoulos, and A. Rapoport, Serum magnesium level and arterial calcification in end-stage renal disease, Kidney International, vol.32, issue.3, pp.388-394, 1987.
DOI : 10.1038/ki.1987.222
URL : https://doi.org/10.1038/ki.1987.222

E. Ishimura, S. Okuno, K. Kitatani, T. Tsuchida, T. Yamakawa et al., Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients, Clinical Nephrology, vol.68, issue.10, pp.222-227, 2007.
DOI : 10.5414/CNP68222

F. Turgut, M. Kanbay, M. R. Metin, E. Uz, and A. Akcay, Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis, International Urology and Nephrology, vol.34, issue.2, pp.1075-1082, 2008.
DOI : 10.1161/01.ATV.10.5.732

C. Schmaderer, M. C. Braunisch, Y. Suttmann, G. Lorenz, D. Pham et al., Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study, Nutrients, vol.44, issue.9, p.926
DOI : 10.1093/ckj/sfv014
URL : http://www.mdpi.com/2072-6643/9/9/926/pdf

R. Margreiter, Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study, The Lancet, vol.359, issue.9308, pp.741-746, 2002.
DOI : 10.1016/S0140-6736(02)07875-3

K. J. Ledeganck, B. Y. De-winter, A. Van-den-driessche, A. Jürgens, J. Bosmans et al., Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation, Nephrology Dialysis Transplantation, vol.42, issue.1, pp.1097-1102
DOI : 10.1007/s11255-009-9547-8
URL : https://academic.oup.com/ndt/article-pdf/29/5/1097/7639196/gft498.pdf

T. Nijenhuis, J. G. Hoenderop, and R. J. Bindels, Downregulation of Ca2+ and Mg2+ Transport Proteins in the Kidney Explains Tacrolimus (FK506)-Induced Hypercalciuria and Hypomagnesemia, Journal of the American Society of Nephrology, vol.15, issue.3, pp.549-557, 2004.
DOI : 10.1097/01.ASN.0000113318.56023.B6
URL : http://jasn.asnjournals.org/content/15/3/549.full.pdf

D. Silva, C. A. De-bragança, A. C. Shimizu, M. H. Sanches, T. R. Fortes et al., Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression, Am. J. Physiol. Renal Physiol, vol.297, pp.916-922, 2009.

T. F. Andoh, E. A. Burdmann, N. Fransechini, D. C. Houghton, and W. M. Bennett, Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506, Kidney International, vol.50, issue.4, pp.1110-1117, 1996.
DOI : 10.1038/ki.1996.417
URL : https://doi.org/10.1038/ki.1996.417

S. Van-laecke and W. Van-biesen, Hypomagnesaemia in kidney transplantation, Transplantation Reviews, vol.29, issue.3, pp.154-160
DOI : 10.1016/j.trre.2015.05.002

C. H. Barton, N. D. Vaziri, D. C. Martin, S. Choi, and S. Alikhani, Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine, The American Journal of Medicine, vol.83, issue.4, pp.693-699, 1987.
DOI : 10.1016/0002-9343(87)90900-4

R. B. Stevens, J. T. Lane, B. P. Boerner, C. D. Miles, T. H. Rigley et al., Single-dose rATG induction at renal transplantation: superior renal function and glucoregulation with less hypomagnesemia, Clinical Transplantation, vol.7, issue.Suppl 8, pp.123-132, 2012.
DOI : 10.1165/ajrcmb/7.1.58

J. Van-de-cauter, J. Sennesael, and P. Haentjens, Long-Term Evolution of the Mineral Metabolism After Renal Transplantation: A Prospective, Single-Center Cohort Study, Transplantation Proceedings, vol.43, issue.9, pp.3470-3475, 2011.
DOI : 10.1016/j.transproceed.2011.09.030

N. Rodrigues, A. Santana, J. Guerra, M. Neves, C. Nascimento et al., Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study, Proc. 2017, pp.799-802
DOI : 10.1016/j.transproceed.2017.01.070

R. Holzmacher, C. Kendziorski, R. Michael-hofman, J. Jaffery, B. Becker et al., Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity, Nephrology Dialysis Transplantation, vol.20, issue.7, pp.1456-1462, 2005.
DOI : 10.1093/ndt/gfg343
URL : https://academic.oup.com/ndt/article-pdf/20/7/1456/5395100/gfh831.pdf

K. Miura, T. Nakatani, T. Asai, S. Yamanaka, S. Tamada et al., ROLE OF HYPOMAGNESEMIA IN CHRONIC CYCLOSPORINE NEPHROPATHY1, Transplantation, vol.73, issue.3, pp.340-347, 2002.
DOI : 10.1097/00007890-200202150-00005

J. Yuan, J. Zhou, B. C. Chen, X. Zhang, H. M. Zhou et al., Magnesium Supplementation Prevents Chronic Cyclosporine Nephrotoxicity via Adjusting Nitric Oxide Synthase Activity, Transplantation Proceedings, vol.37, issue.4, pp.1892-1895, 2005.
DOI : 10.1016/j.transproceed.2005.02.098

T. Asai, T. Nakatani, S. Yamanaka, S. Tamada, T. Kishimoto et al., Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism., Transplantation, vol.74, issue.6, pp.784-791, 2002.
DOI : 10.1097/00007890-200209270-00009
URL : http://pdfs.journals.lww.com/transplantjournal/2002/09270/Magnesium_supplementation_prevents_experimental.9.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1503423879926;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdGlb2qsojlvlytk14LkMXSBSiqme1g0n1y2s0XEuLz4BV84meViH58xhSIIN8uhDL;hash|M+KUj4MNFndv3bxmZN8hWg==

T. Asai, T. Nakatani, S. Tamada, N. Kuwabara, S. Yamanaka et al., Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: Role in beneficial effects of magnesium supplementation, Transplantation, vol.75, pp.1040-1044, 2003.

P. T. Pham, P. T. Pham, S. V. Pham, J. M. Miller, and P. T. Pham, Hypomagnesemia in Patients with Type 2 Diabetes, Clinical Journal of the American Society of Nephrology, vol.2, issue.2, pp.366-373, 2007.
DOI : 10.2215/CJN.02960906

H. Geiger and C. Wanner, Magnesium in disease, Clinical Kidney Journal, vol.173, issue.4, pp.25-38
DOI : 10.1016/0002-9378(95)91364-5

P. C. Pham, P. M. Pham, P. Pham, S. V. Pham, H. V. Pham et al., Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2, Clinical Nephrology, vol.63, issue.06, pp.429-436, 2005.
DOI : 10.5414/CNP63429

R. Lopez-ridaura, W. C. Willett, E. B. Rimm, S. Liu, M. J. Stampfer et al., Magnesium Intake and Risk of Type 2 Diabetes in Men and Women, Diabetes Care, vol.27, issue.1, pp.134-140, 2004.
DOI : 10.2337/diacare.27.1.134

Y. Song, J. E. Manson, J. E. Buring, and S. Liu, Dietary Magnesium Intake in Relation to Plasma Insulin Levels and Risk of Type 2 Diabetes in Women, Diabetes Care, vol.27, issue.1, pp.59-65, 2004.
DOI : 10.2337/diacare.27.1.59

X. Fang, K. Wang, D. Han, X. He, J. Wei et al., Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose???response meta-analysis of prospective cohort studies, BMC Medicine, vol.18, issue.4, pp.14-210, 2016.
DOI : 10.1093/ije/18.4.858

W. H. Kao, A. R. Folsom, F. J. Nieto, J. P. Mo, R. L. Watson et al., Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus, Archives of Internal Medicine, vol.159, issue.18, pp.2151-2159, 1999.
DOI : 10.1001/archinte.159.18.2151
URL : http://archinte.jamanetwork.com/data/journals/intemed/11951/ioi81216.pdf

J. L. Nadler, T. Buchanan, R. Natarajan, I. Antonipillai, and R. Bergman, Magnesium deficiency produces insulin resistance and increased thromboxane synthesis., Hypertension, vol.21, issue.6_Pt_2, pp.1024-1029, 1993.
DOI : 10.1161/01.HYP.21.6.1024
URL : http://hyper.ahajournals.org/content/hypertensionaha/21/6_Pt_2/1024.full.pdf

S. Van-laecke and W. Van-biesen, Vanholder, R. Hypomagnesaemia, the kidney and the vessels, Nephrol. Dial. Transplant, vol.2012, issue.27, pp.4003-4010

M. Rodriguez-moran and F. Guerrero-romero, Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects: A randomized double-blind controlled trial, Diabetes Care, vol.26, issue.4, pp.1147-1152, 2003.
DOI : 10.2337/diacare.26.4.1147
URL : http://care.diabetesjournals.org/content/diacare/26/4/1147.full.pdf

B. L. Kasiske, J. J. Snyder, D. Gilbertson, and A. J. Matas, Diabetes Mellitus after Kidney Transplantation in the United States, American Journal of Transplantation, vol.72, issue.6, pp.178-185, 2003.
DOI : 10.1097/00007890-200109270-00015

J. Augusto, J. Subra, A. Duveau, J. Rakotonjanahary, C. Dussaussoy et al., Relation Between Pretransplant Magnesemia and the Risk of New Onset Diabetes After Transplantation Within the First Year of Kidney Transplantation, Transplantation, vol.97, issue.11, pp.1155-1160, 2014.
DOI : 10.1097/01.TP.0000440950.22133.a1

C. J. Yates, S. Fourlanos, J. Hjelmesaeth, P. G. Colman, and S. J. Cohney, New-Onset Diabetes After Kidney Transplantation-Changes and Challenges, American Journal of Transplantation, vol.348, issue.suppl 2, pp.820-828, 2012.
DOI : 10.1056/NEJMoa021778
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2011.03855.x/pdf

F. C. Mazali, C. A. Lalli, G. Alves-filho, and M. Mazzali, Posttransplant Diabetes Mellitus: Incidence and Risk Factors, Transplantation Proceedings, vol.40, issue.3, pp.764-766, 2008.
DOI : 10.1016/j.transproceed.2008.03.018

B. D. Maes, D. Kuypers, T. Messiaen, P. Evenepoel, C. Mathieu et al., POSTTRANSPLANTATION DIABETES MELLITUS IN FK-506-TREATED RENAL TRANSPLANT RECIPIENTS: ANALYSIS OF INCIDENCE AND RISK FACTORS, Transplantation, vol.72, issue.10, pp.1655-1661, 2001.
DOI : 10.1097/00007890-200111270-00014

S. Van-laecke, W. Van-biesen, F. Verbeke, D. De-bacquer, P. Peeters et al., Posttransplantation Hypomagnesemia and Its Relation with Immunosuppression as Predictors of New-Onset Diabetes after Transplantation, American Journal of Transplantation, vol.11, issue.4 Pt 1, pp.2140-2149, 2009.
DOI : 10.1080/07315724.1989.10720330

J. W. Huang, O. Famure, Y. Li, and S. J. Kim, Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation, Journal of the American Society of Nephrology, vol.27, issue.6, pp.1793-1800, 2016.
DOI : 10.1681/ASN.2015040391
URL : http://jasn.asnjournals.org/content/27/6/1793.full.pdf

W. Hayes, S. Boyle, A. Carroll, D. Bockenhauer, and S. D. Marks, Hypomagnesemia and increased risk of new-onset diabetes mellitus after transplantation in pediatric renal transplant recipients, Pediatric Nephrology, vol.27, issue.5, pp.879-884, 2017.
DOI : 10.1111/tri.12287
URL : https://link.springer.com/content/pdf/10.1007%2Fs00467-016-3571-6.pdf

R. Chanchlani, S. Kim, E. D. Kim, T. Banh, K. Borges et al., Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients, Nephrology Dialysis Transplantation, vol.5, issue.1, pp.2017-1579
DOI : 10.2215/CJN.09481209

J. M. Osorio, J. Bravo, A. Pérez, C. Ferreyra, and A. Osuna, Magnesemia in Renal Transplant Recipients: Relation With Immunosuppression and Posttransplant Diabetes, Transplantation Proceedings, vol.42, issue.8, pp.2910-2913, 2010.
DOI : 10.1016/j.transproceed.2010.08.016

L. Santos, E. Rodrigo, C. Piñera, C. Robledo, R. Palomar et al., Elevated Serum Gamma-Glutamyltransferase and Hypomagnesemia Are Not Related With New-Onset Diabetes After Transplantation, Transplantation Proceedings, vol.42, issue.8, pp.2914-2916, 2010.
DOI : 10.1016/j.transproceed.2010.07.057

S. Van-laecke, F. Desideri, A. Geerts, H. Van-vlierberghe, F. Berrevoet et al., Colle, I. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation. Liver Transplant, pp.1278-1287, 2010.

S. Van-laecke, E. V. Nagler, Y. Taes, W. Van-biesen, P. Peeters et al., The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial, Transplant International, vol.39, issue.9, pp.895-902, 2014.
DOI : 10.1016/j.diabet.2012.10.007

S. Van-laecke, R. Caluwe, I. Huybrechts, E. V. Nagler, R. Vanholder et al., Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial, Annals of Transplantation, vol.22, pp.524-531, 2017.
DOI : 10.12659/AOT.903439

A. I. Sánchez-fructuoso, J. M. Santín-cantero, I. Pérez-flores, R. Valero-san-cecilio, and N. Calvo-romero, Changes in Magnesium and Potassium Homeostasis after Conversion from a Calcineurin Inhibitor Regimen to an mTOR Inhibitor???Based Regimen, Transplantation Proceedings, vol.42, issue.8, pp.3047-3049, 2010.
DOI : 10.1016/j.transproceed.2010.07.081

N. Murakami, L. V. Riella, and T. Funakoshi, Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis, American Journal of Transplantation, vol.367, issue.10, pp.2317-2327, 2014.
DOI : 10.1056/NEJMoa1204166

P. Grimbert, Thaunat, O. mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: Where are we now?, Transpl. Int, vol.2017, issue.30, pp.647-657

R. Zhang, P. Kumar, E. Reisin, and T. Ramcharan, Kidney Transplantation: The Evolving Challenges, The American Journal of the Medical Sciences, vol.328, issue.3, pp.156-161, 2004.
DOI : 10.1097/00000441-200409000-00004

J. A. Maier, C. Malpuech-brugère, W. Zimowska, Y. Rayssiguier, and A. Mazur, Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1689, issue.1, pp.13-21, 2004.
DOI : 10.1016/j.bbadis.2004.01.002

T. M. Paravicini, A. Yogi, A. Mazur, and R. M. Touyz, Dysregulation of Vascular TRPM7 and Annexin-1 Is Associated With Endothelial Dysfunction in Inherited Hypomagnesemia, Hypertension, vol.53, issue.2, pp.423-429, 2009.
DOI : 10.1161/HYPERTENSIONAHA.108.124651
URL : http://hyper.ahajournals.org/content/hypertensionaha/53/2/423.full.pdf

F. Liao, A. R. Folsom, and F. L. Brancati, Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study, American Heart Journal, vol.136, issue.3, pp.480-490, 1998.
DOI : 10.1016/S0002-8703(98)70224-8

T. Hashimoto, A. Hara, T. Ohkubo, M. Kikuya, Y. Shintani et al., Serum Magnesium, Ambulatory Blood Pressure, and Carotid Artery Alteration: The Ohasama Study, American Journal of Hypertension, vol.25, issue.6, pp.1292-1298, 2010.
DOI : 10.1080/07315724.2006.10719566
URL : https://academic.oup.com/ajh/article-pdf/23/12/1292/6630109/23_12_1292.pdf

K. Kisters, B. Gremmler, and M. Hausberg, Magnesium and arterial stiffness, Hypertension, vol.47, 2006.

M. Shechter, M. Sharir, M. J. Labrador, J. Forrester, B. Silver et al., Oral Magnesium Therapy Improves Endothelial Function in Patients With Coronary Artery Disease, Circulation, vol.102, issue.19, pp.2353-2358, 2000.
DOI : 10.1161/01.CIR.102.19.2353
URL : http://circ.ahajournals.org/content/102/19/2353.full.pdf

Z. A. Massy and T. Drüeke, Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival, Clinical Kidney Journal, vol.20, issue.4, pp.52-61
DOI : 10.1007/s11255-008-9410-3
URL : https://academic.oup.com/ckj/article-pdf/5/Suppl_1/i52/1229900/sfr167.pdf

T. Nguyen and R. W. Steiner, A trial of oral magnesium supplementation in renal transplant recipients receiving cyclosporine, Transplantation Proceedings, vol.30, issue.8, pp.4317-4319, 1998.
DOI : 10.1016/S0041-1345(98)01424-9

S. Van-laecke, C. Maréchal, F. Verbeke, P. Peeters, W. Van-biesen et al., The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients, Nephrology Dialysis Transplantation, vol.99, issue.6, pp.2362-2369, 2011.
DOI : 10.1080/07315724.1989.10720330